HF
CSBR icon

HRT Financial’s Champions Oncology CSBR Stock Holding History

HRT Financial’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-12,541
Closed -$128K – 3322
2021
Q3 		$128K Sell
12,541
-2,426
-16% -$24.7K ﹤0.01% 2829
2021
Q2 		$153K Buy
+14,967
New +$152K ﹤0.01% 2477

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
OMC
Overbrook Management Corp New York $529M AUM 31.5% 1-Year Est. Return

HRT Financial's CSBR Position: Q4 2021 in Review

HRT Financial sold out of Champions Oncology (CSBR) in Q4 2021, closing a stake of 12,541 shares — an estimated $128K sold.

HRT Financial first reported a position in CSBR in Q2 2021 and held it in 2 quarters. The position peaked at $153K in Q2 2021. 31 funds tracked by Wall St. Rank hold CSBR as of Q4 2021.

  • HRT Financial reported no remaining Champions Oncology position as of Q4 2021 after selling out during the quarter.
  • HRT Financial sold 12,541 Champions Oncology shares in Q4 2021, an estimated $128K.
  • HRT Financial first reported a position in Champions Oncology in Q2 2021 and held it in 2 quarters.
  • HRT Financial's Champions Oncology position peaked at $153K in Q2 2021.
  • 31 funds tracked by Wall St. Rank held Champions Oncology as of Q4 2021.

Based on HRT Financial's 13F filing for Q4 2021, filed 14 Feb 2022.